Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Induction Healthcare Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 8.50.
Current Consensus is
N/A
The current consensus among 0 investment analysts is to n/a stock in Induction Healthcare Group. This rating has held steady since June 2023, when it changed from a Buy consensus rating.
Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom. The company offers Zesty, a patient engagement platform that provides smart appointment management, paperless letters, targeted questionnaires, and patient information; and Attend Anywhere for video consultations. It also offers registration, messaging, integration, and analytics and reporting platforms. Induction Healthcare Group PLC was incorporated in 2019 and is based in London, the United Kingdom.
Read More